Wilfong Diane E.
SEC CIK 1374988 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | SVP, CAO, Ctrl | 46.3K | — | $2.81M | 30 | 2021-08-10 | 2025-09-10 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Wilfong Diane E. made no open-market trades at GILD in the last 12 months.
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Wilfong Diane E. | CAO, Interim Corp Ctrl | F - Tax | $115.25 | -338 | 46.3K | -0.7% | -$39.0K |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Wilfong Diane E. | CAO, Interim Corp Ctrl | M - OptEx | — | +921 | 46.6K | +2% | — |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Wilfong Diane E. | CAO, Interim Corp Ctrl | M - OptEx | — | +920 | 46.0K | +2% | — |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Wilfong Diane E. | CAO, Interim Corp Ctrl | F - Tax | $110.09 | -340 | 45.7K | -0.7% | -$37.4K |
| D | 2023-02-07 | 2023-02-06 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +1,864 | 32.6K | +6% | — |
| D | 2023-02-07 | 2023-02-06 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $86.36 | -565 | 32.0K | -2% | -$48.8K |
| 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $84.02 | -1,244 | 30.7K | -4% | -$104.5K | |
| M | 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | A - Grant | $0.00 | +5,884 | 27.9K | +27% | $0 |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +318 | 28.7K | +1% | — |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $87.97 | -149 | 28.5K | -0.5% | -$13.1K |
| D | 2022-11-10 | 2022-11-09 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $63.91 | +6,416 | 34.7K | +23% | +$410.0K |
| D | 2022-11-10 | 2022-11-09 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | S - Sale+OE | $83.50 | -6,416 | 28.3K | -18% | -$535.7K |
| D | 2022-11-02 | 2022-11-01 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $72.70 | +16.3K | 44.6K | +57% | +$1.18M |
| D | 2022-11-02 | 2022-11-01 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | S - Sale+OE | $79.25 | -16.3K | 28.3K | -36% | -$1.29M |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $65.28 | -148 | 28.3K | -0.5% | -$9,661 |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +318 | 28.5K | +1% | — |
| D | 2022-08-11 | 2022-08-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $63.14 | -1,066 | 28.2K | -4% | -$67.3K |
| D | 2022-08-11 | 2022-08-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +2,479 | 29.2K | +9% | — |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +317 | 26.9K | +1% | — |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $60.74 | -148 | 26.8K | -0.6% | -$8,990 |
| DM | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $0.00 | +3,297 | 27.5K | +14% | $0 |
| D | 2022-03-14 | 2022-03-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $57.92 | -935 | 26.6K | -3% | -$54.2K |
| D | 2022-02-08 | 2022-02-06 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $63.90 | -520 | 24.2K | -2% | -$33.2K |
| D | 2022-02-08 | 2022-02-06 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $0.00 | +1,864 | 24.7K | +8% | $0 |
| 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $67.34 | -394 | 22.9K | -2% | -$26.5K | |
| M | 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | A - Grant | $0.00 | +2,871 | 22.1K | +15% | $0 |
| DM | 2021-08-18 | 2021-08-17 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | $68.08 | +13.6K | 34.0K | +67% | +$926.5K |
| D | 2021-08-18 | 2021-08-17 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | S - Sale+OE | $72.50 | -13.6K | 20.4K | -40% | -$986.7K |
| D | 2021-08-12 | 2021-08-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | F - Tax | $69.24 | -907 | 20.4K | -4% | -$62.8K |
| D | 2021-08-12 | 2021-08-10 | GILD | Gilead Sciences | Wilfong Diane E. | SVP, CAO, Ctrl | M - OptEx | — | +2,480 | 21.3K | +13% | — |
Purchase Sale Sale after option exercise All abbreviations